株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

デジタル治療の世界市場:用途(糖尿病、肥満、心血管疾患、中枢神経疾患、呼吸器疾患、禁煙)、エンドユーザー、地域別

Digital Therapeutics Market By Application (Diabetes, Obesity, CVD, CNS Disorder, Respiratory Diseases, Smoking Cessation), By End Use (Patients, Providers, Payers, Employers), And Segment Forecasts, 2014 - 2025

発行 Grand View Research, Inc. 商品コード 478612
出版日 ページ情報 英文 90 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.97円で換算しております。
Back to Top
デジタル治療の世界市場:用途(糖尿病、肥満、心血管疾患、中枢神経疾患、呼吸器疾患、禁煙)、エンドユーザー、地域別 Digital Therapeutics Market By Application (Diabetes, Obesity, CVD, CNS Disorder, Respiratory Diseases, Smoking Cessation), By End Use (Patients, Providers, Payers, Employers), And Segment Forecasts, 2014 - 2025
出版日: 2017年07月10日 ページ情報: 英文 90 Pages
概要

当レポートでは、デジタル治療の世界市場について調査し、全体および用途・エンドユーザー・地域別の成長予測、主な市場促進・阻害要因、競合情勢、企業プロファイルなどについて分析・推計しております。

第1章 調査範囲と調査手法

第2章 エグゼクティブサマリー

第3章 デジタル治療の市場動向

  • 市場範囲と市場区分
  • デジタル治療:市場力学
    • 市場促進要因
    • 市場阻害要因
  • 市場の機会:重要度別
  • SWOT分析
  • 産業分析‐ファイブフォース分析
  • デジタル治療市場のポジション分析

第4章 デジタル治療市場の動向と予測:用途別

  • デジタル治療市場の分析:用途別
    • 糖尿病
    • 肥満
    • 心血管疾患(CVD)
    • 中枢神経疾患(CNS)
    • 呼吸器疾患
    • 禁煙
    • その他

第5章 デジタル治療市場の動向と予測:エンドユーザー別

  • デジタル治療市場の分析:エンドユーザー別
    • 患者
    • 医療提供者
    • 保険者
    • 雇用者
    • その他

第6章 デジタル治療市場の動向と予測:地域別

  • デジタル治療市場のシェアの分析:地域別
  • 北米(米国、カナダ)
    • デジタル治療市場:用途別
    • デジタル治療市場:エンドユーザー別
  • 欧州(ドイツ、英国)
    • デジタル治療市場:用途別
    • デジタル治療市場:エンドユーザー別
  • アジア太平洋(中国、インド)
    • デジタル治療市場:用途別
    • デジタル治療市場:エンドユーザー別
  • ラテンアメリカ(ブラジル・メキシコ)
    • デジタル治療市場:用途別
    • デジタル治療市場:エンドユーザー別
  • 中東・アフリカ
    • デジタル治療市場:用途別
    • デジタル治療市場:エンドユーザー別

第7章 競合環境

  • 企業プロファイル
目次
Product Code: GVR-1-68038-768-1

The global digital therapeutics market is anticipated to reach USD 9.4 billion by 2025, according to a new report by Grand View Research, Inc. The growth of the market is catapulted by increasing incidences of chronic diseases, increasing emphasis on preventive healthcare, the need to curb healthcare expenditures, and added benefits offered by digital therapeutics. Rise in number of venture capitalists that are investing in the market is another factor that is accelerating its growth.

Digital therapeutics, commonly known as software-for drugs has been gaining much attention due to the number of benefits it offers to patients that utilize it. Continuous monitoring of patient's vital stats, ability to ensure adherence to medications, prompt reminders are some of the most important benefits offered by digital therapeutics.

With an increase in the internet usage and dependency over smartphones, digital therapeutics offers easy tracking and monitoring of patients and their vital stats without intervention. This serves in a discrete and non-interventional manner to persuade individuals to adopt healthier lifestyles and improve physical well-being. Captivating design, extended assessment, and digital tracking are features that are attributing to increasing adoption of digital therapeutics by patients, employers, providers and others.

The North American region contributed to the largest market share owing to technologically advanced medical infrastructure and successful execution of ambulatory health in their healthcare system. Emerging countries like India, China and Brazil are also expected to flourish during the forecast period owing to adoption of enhanced healthcare infrastructure and medical technologies to curb the prevention of chronic diseases.

Further Key Findings From the Study Suggest:

The global digital therapeutics market $1.7 Billion in 2016 and is expected to grow at 21.0% CAGR from 2017 to 2025

Diabetes is expected to gain the largest market share on the basis of application owing to increasing incidence rates globally and preventive steps taken to reduce them

Obesity is also expected to account for a considerable market share due to various healthcare reforms to curb the disease initially and prevent further costs associated with the disease

The adoption of digital therapeutics offers reduction in healthcare costs associated with diseases like diabetes and obesity and are thus being used on an increasing scale

Digital tracking, continuous monitoring, and management of physical activity and eating habits are factors that are propelling the growth of the market

Increasing usage in preventive areas for a wide range of diseases and disorders like respiratory disorders, CVD, and CNS disease are attributes that are bringing about growth of the market

Patients accounted for the largest market share in the end-user's segment owing to user-friendly interface and effective management of diseases

The North American region accounted for the highest revenue owing to technological advancement and healthcare expenditure to curb rise in number of chronic diseases

The Asia Pacific region is expected to garner considerable growth during the forecast period owing to increasing adoption of advanced healthcare technologies and rise in number of chronic diseases

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research Scope & Assumptions
  • 1.2. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Digital Therapeutics: Market Summary

Chapter 3. Digital Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Segmentation & Scope
  • 3.2. Digital Therapeutics: Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Key Opportunities Prioritized
  • 3.4. Digital Therapeutics - SWOT Analysis, by Factor (political & legal, economic and technological)
  • 3.5. Industry Analysis - Porter's
  • 3.6. Digital Therapeutics Market: Market Position Analysis, 2016

Chapter 4. Digital Therapeutics Market: Application Estimates & Trend Analysis

  • 4.1. Digital Therapeutics Market: Application Movement Analysis
    • 4.1.1. Diabetes
      • 4.1.1.1. Diabetes market, 2014 - 2025 (USD Million)
    • 4.1.2. Obesity
      • 4.1.2.1. Obesity market, 2014 - 2025 (USD Million)
    • 4.1.3. CVD
      • 4.1.3.1. CVD market, 2014 - 2025 (USD Million)
    • 4.1.4. CNS disease
      • 4.1.4.1. CNS disease market, 2014 - 2025 (USD Million)
    • 4.1.5. Respiratory diseases
      • 4.1.5.1. Respiratory diseases market, 2014 - 2025 (USD Million)
    • 4.1.6. Smoking cessation
      • 4.1.6.1. Smoking cessation market, 2014 - 2025 (USD Million)
    • 4.1.7. Others
      • 4.1.7.1. Others market, 2014 - 2025 (USD Million)

Chapter 5. Digital Therapeutics Market: End use Estimates & Trend Analysis

  • 5.1. Digital Therapeutics Market: End use Movement Analysis
  • 5.2. Patients
    • 5.2.1. Patients market, 2014 - 2025 (USD Million)
  • 5.3. Providers
    • 5.3.1. Providers market, 2014 - 2025 (USD Million)
  • 5.4. Payers
    • 5.4.1. Payers market, 2014 - 2025 (USD Million)
  • 5.5. Employers
    • 5.5.1. Employers market, 2014 - 2025 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market, 2014 - 2025 (USD Million)

Chapter 6. Digital Therapeutics: Regional Estimates & Trend Analysis, by Application and End use

  • 6.1. Digital Therapeutics Market Share (%) Analysis, by Region, 2016 & 2025
  • 6.2. North America
    • 6.2.1. U.S.
      • 6.2.1.1. U.S. digital therapeutics market, by application, 2014 - 2025 (USD Million)
      • 6.2.1.2. U.S. digital therapeutics market, by end use, 2014 - 2025 (USD Million)
    • 6.2.2. Canada
      • 6.2.2.1. Canada digital therapeutics market, by application, 2014 - 2025 (USD Million)
      • 6.2.2.2. Canada digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 6.3. Europe
    • 6.3.1. Germany
      • 6.3.1.1. Germany digital therapeutics market, by application, 2014 - 2025 (USD Million)
      • 6.3.1.2. Germany digital therapeutics market, by end use, 2014 - 2025 (USD Million)
    • 6.3.2. U.K.
      • 6.3.2.1. U.K. digital therapeutics market, by application, 2014 - 2025 (USD Million)
      • 6.3.2.2. U.K. digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 6.4. Asia-Pacific
    • 6.4.1. China
      • 6.4.1.1. China digital therapeutics market, by application, 2014 - 2025 (USD Million)
      • 6.4.1.2. China digital therapeutics market, by end use, 2014 - 2025 (USD Million)
    • 6.4.2. India
      • 6.4.2.1. India digital therapeutics market, by application, 2014 - 2025 (USD Million)
      • 6.4.2.2. India digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Brazil
      • 6.5.1.1. Brazil digital therapeutics market, by application, 2014 - 2025 (USD Million)
      • 6.5.1.2. Brazil digital therapeutics market, by end use, 2014 - 2025 (USD Million)
    • 6.5.2. Mexico
      • 6.5.2.1. Mexico digital therapeutics market, by application, 2014 - 2025 (USD Million)
      • 6.5.2.2. Mexico digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 6.6. MEA
    • 6.6.1. South Africa
      • 6.6.1.1. South Africa digital therapeutics market, by application, 2014 - 2025 (USD Million)
      • 6.6.1.2. South Africa digital therapeutics market, by end use, 2014 - 2025 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Profiles
    • 7.1.1. Proteus Digital Health
      • 7.1.1.1. Company overview
      • 7.1.1.2. Product benchmarking
      • 7.1.1.3. Strategic initiatives
    • 7.1.2. Omada Health, Inc.
      • 7.1.2.1. Company overview
      • 7.1.2.2. Product benchmarking
      • 7.1.2.3. Strategic initiatives
    • 7.1.3. WellDoc Inc.
      • 7.1.3.1. Company overview
      • 7.1.3.2. Product benchmarking
      • 7.1.3.3. Strategic initiatives
    • 7.1.4. 2Morrow, Inc.
      • 7.1.4.1. Company overview
      • 7.1.4.2. Product benchmarking
      • 7.1.4.3. Strategic initiatives
    • 7.1.5. Livongo Health
      • 7.1.5.1. Company overview
      • 7.1.5.2. Product benchmarking
      • 7.1.5.3. Strategic initiatives
    • 7.1.6. Propeller Health
      • 7.1.6.1. Company overview
      • 7.1.6.2. Product benchmarking
      • 7.1.6.3. Strategic initiatives
    • 7.1.7. Twinehealth
      • 7.1.7.1. Company overview
      • 7.1.7.2. Product benchmarking
      • 7.1.7.3. Strategic initiatives
    • 7.1.8. Canary Health, Inc.
      • 7.1.8.1. Company overview
      • 7.1.8.2. Product benchmarking
      • 7.1.8.3. Strategic initiatives
    • 7.1.9. Mango Health, Inc.
      • 7.1.9.1. Company overview
      • 7.1.9.2. Product benchmarking
      • 7.1.9.3. Strategic initiatives
    • 7.1.10. Noom Health, Inc.
      • 7.1.10.1. Company overview
      • 7.1.10.2. Product bnchmarking
      • 7.1.10.3. Strategic initiatives

List of Tables

  • 1. Factors used in segment share estimation
  • 2. List of secondary data sources
  • 3. Primary interview details, by source
  • 4. Primary interview details, by region
  • 5. North America digital therapeutics market, by country, 2014 - 2025 (USD Million)
  • 6. North America digital therapeutics market, by application, 2014 - 2025 (USD Million)
  • 7. North America digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 8. U.S. digital therapeutics market, by application, 2014 - 2025 (USD Million)
  • 9. U.S. digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 10. Canada digital therapeutics market, by application, 2014 - 2025 (USD Million)
  • 11. Canada digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 12. Europe digital therapeutics market, by country, 2014 - 2025 (USD Million)
  • 13. Europe digital therapeutics market, by application, 2014 - 2025 (USD Million)
  • 14. Europe digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 15. Germany digital therapeutics market, by application, 2014 - 2025 (USD Million)
  • 16. Germany digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 17. UK digital therapeutics market, by application, 2014 - 2025 (USD Million)
  • 18. UK digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 19. Asia Pacific digital therapeutics market, by country, 2014 - 2025 (USD Million)
  • 20. Asia Pacific digital therapeutics market, by application, 2014 - 2025 (USD Million)
  • 21. Asia Pacific digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 22. China digital therapeutics market, by application, 2014 - 2025 (USD Million)
  • 23. China digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 24. India digital therapeutics market, by application, 2014 - 2025 (USD Million)
  • 25. India digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 26. Latin America digital therapeutics market, by country, 2014 - 2025 (USD Million)
  • 27. Latin America digital therapeutics market, by application, 2014 - 2025 (USD Million)
  • 28. Latin America digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 29. Brazil digital therapeutics market, by application, 2014 - 2025 (USD Million)
  • 30. Brazil digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 31. Mexico digital therapeutics market, by application, 2014 - 2025 (USD Million)
  • 32. Mexico digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 33. MEA digital therapeutics market, by country, 2014 - 2025 (USD Million)
  • 34. MEA digital therapeutics market, by application, 2014 - 2025 (USD Million)
  • 35. MEA digital therapeutics market, by end use, 2014 - 2025 (USD Million)
  • 36. South Africa digital therapeutics market, by application, 2014 - 2025 (USD Million)
  • 37. South Africa digital therapeutics market, by end use, 2014 - 2025 (USD Million)

List of Figures

  • 1. Market summary
  • 2. Market trends & outlook
  • 3. Market segmentation & scope
  • 4. Market driver relevance analysis (Current & future impact)
  • 5. Key opportunities prioritized
  • 6. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 7. Porter's Five Forces Analysis
  • 8. Digital therapeutics market: Application outlook key takeaways
  • 9. Digital therapeutics market: Application movement analysis
  • 10. Diabetes market, 2014 - 2025 (USD Million)
  • 11. Obesity market, 2014 - 2025 (USD Million)
  • 12. CVD market, 2014 - 2025 (USD Million)
  • 13. CNS disease market, 2014 - 2025 (USD Million)
  • 14. Respiratory diseases market, 2014 - 2025 (USD Million)
  • 15. Smoking cessation market, 2014 - 2025 (USD Million)
  • 16. Others market, 2014 - 2025 (USD Million)
  • 17. Digital therapeutics market: End use outlook key takeaways
  • 18. Digital therapeutics market: End use movement analysis
  • 19. Patients market, 2014 - 2025 (USD Million)
  • 20. Providers market, 2014 - 2025 (USD Million)
  • 21. Payers market, 2014 - 2025 (USD Million)
  • 22. Employers market, 2014 - 2025 (USD Million)
  • 23. Others market, 2014 - 2025 (USD Million)
  • 24. Regional market place: Key takeaways
  • 25. Regional outlook, 2015 & 2025
Back to Top